eMS News

Tecfidera: Clinical Trials Tecifera (previously known as BG-12), was approved by the FDA in March 2013 for relapsing-remitting forms of MS. An oral fumarate derivative, Tecfidera has been shown to…

Community First Foundation and FirstBank Announce Colorado Gives Day 2013 For the fourth year, online initiative encourages Coloradans to “Give Where You Live” and raise millions for nonprofits News release…

What Are MS Patients Shopping for in the Health Insurance Marketplace?Jill K Leslie, Public Health Advisor On March 23, 2010 the Affordable Care Act (ACA) became law and will create some…

After 22 years of dedicated service to the Rocky Mountain MS Center, Karen Wenzel announced her resignation as Rocky Mountain MS Center’s Executive Director – a position she has held…

Join Rocky Mountain MS Center for this seminar as we explore Social Security Disability Benefits (SSDI) and other legal issues pertinent to people living with MS.   Featuring *Tom Stewart, PA-D, JD, MS – Rocky…

The Rocky Mountain MS Center is aSLOW Food Denver C.A.F.E. Grant Finalist! Support the Rocky Mountain MS Center and the King Adult Day Enrichment Program (KADEP) by joining us for…

Participants with multiple sclerosisare needed for a research study on:Arbaclofen (an extended release anti-spasticity investigational medication) Purpose of the study – Researchers from the University of Colorado Anschutz Medical Campus…

This month, Dr. Alvarez became the newest member of the Rocky Mountain MS Center at Anschutz Medical Campus team—making him the seventh fellowship-trained MS specialist on staff. Please tell us about…

Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. In people with MS, specific immune system cells (T-cells) misidentify elements of the brain and spinal cord as…

InforMS – Summer 2013   Featured Article: Brain Drain MS cognitive problems are common, confusing,usually mild, mostly manageable and always draining.     Welcome to the 2013 DIGITAL Summer Issue…